Andrew M Courtwright
Overview
Explore the profile of Andrew M Courtwright including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Courtwright A, Prenner S, Doyon J, Claridge T, Blumberg E, Bermudez C, et al.
Transpl Infect Dis
. 2025 Feb;
:e70013.
PMID: 39995018
Background: This was a single-center pilot study to determine the safety and efficacy of transplanting lungs from hepatitis B virus (HBV) nucleic acid positive (NAT+) donors to HBV vaccinated (sAb+)...
2.
Mezochow A, Mezochow A, Clausen E, Clausen E, Whitaker K, Whitaker K, et al.
Am J Transplant
. 2025 Jan;
PMID: 39884651
Universal cytomegalovirus (CMV) prophylaxis is recommended for at-risk lung transplant recipients. Valganciclovir (VGCV) is currently the preferred first-line agent. VGCV-related myelosuppression, however, can lead to drug discontinuation or reduction in...
3.
Federico L, Diamond J, Kamoun M, Crespo M, Bermudez C, Courtwright A
Ann Thorac Surg Short Rep
. 2025 Jan;
2(4):836-841.
PMID: 39790585
Background: Extracorporeal membrane oxygenation (ECMO) is increasingly used as a bridge to lung transplantation. Although other mechanical circulatory support devices have been associated with anti-human leukocyte antigen antibody formation, including...
4.
Courtwright A, Whyte A, Devarajan J, Fritz A, Martin A, Wilkey B, et al.
J Cardiothorac Vasc Anesth
. 2024 Sep;
38(11):2516-2545.
PMID: 39256076
These highlights focus on the research in lung transplantation (LTX) that was published in 2022 and includes the assessment and optimization of candidates for LTX, donor optimization, the use of...
5.
Grobman B, Diamond J, Goldberg H, Courtwright A
Transplant Proc
. 2024 Aug;
56(7):1646-1653.
PMID: 39147614
Introduction: Patients with advanced lung disease who have HLA antibodies against potential donors have reduced opportunities for transplant. Not all HLA antibodies, however, have the same impact on post-transplant outcomes....
6.
Courtwright A, Diamond J, Sandorfi N, Goldberg H
Clin Transplant
. 2024 Aug;
38(8):e15426.
PMID: 39136242
Background: The development of connective tissue disease-associated lung diseases (CTD-LD) occurs in association with specific human leukocyte antigens (HLA). For CTD-LD patients who require lung transplant, it is unknown whether...
7.
Clancy M, Tevald M, Adler J, Butler K, Courtwright A, Diamond J, et al.
Phys Ther
. 2023 Dec;
104(3).
PMID: 38109784
Objective: The goal of this case report is to describe the process, challenges, and opportunities of implementing rehabilitation for individuals who were critically ill and required both mechanical ventilation (MV)...
8.
Diamond J, Cantu E, Calfee C, Anderson M, S Clausen E, Shashaty M, et al.
Am J Respir Crit Care Med
. 2023 Sep;
209(1):91-100.
PMID: 37734031
Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Prior studies implicated proxy-defined donor smoking as a risk factor for PGD and mortality....
9.
Rubin E, Robinson E, Cremens M, McCoy T, Courtwright A
J Bioeth Inq
. 2023 Jun;
20(3):457-466.
PMID: 37380828
In 2015, the major critical care societies issued guidelines outlining a procedural approach to resolving intractable conflict between healthcare professionals and surrogates over life-sustaining treatments (LST). We report our experience...
10.
Clancy M, Adler J, Tevald M, Zaleski D, Fluehr L, Wamsley C, et al.
Phys Ther
. 2023 May;
103(5).
PMID: 37249530
Objective: Severe coronavirus disease 2019 (COVID-19) can result in irreversible lung damage, with some individuals requiring lung transplantation. The purpose of this case series is to describe the initial experience...